dc.contributor.author | HEALY, ANNE | en |
dc.date.accessioned | 2017-01-17T14:16:41Z | |
dc.date.available | 2017-01-17T14:16:41Z | |
dc.date.issued | 2016 | en |
dc.date.submitted | 2016 | en |
dc.identifier.citation | Simon A, Amaro MI, Healy AM, Cabral LM, de Sousa VP, Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation, International Journal of Pharmaceutics, 512, 1, 2016, 234 - 241 | en |
dc.identifier.other | Y | en |
dc.description | PUBLISHED | en |
dc.description | Export Date: 13 December 2016 | en |
dc.description.abstract | In the present study, in vitro permeation experiments in a Franz diffusion cell were performed using different synthetic polymeric membranes and pig ear skin to evaluate a rivastigmine (RV) transdermal drug delivery system. In vitro-in vivo correlations (IVIVC) were examined to determine the best model membrane. In vitro permeation studies across different synthetic membranes and skin were performed for the Exelon® Patch (which contains RV), and the results were compared. Deconvolution of bioavailability data using the Wagner–Nelson method enabled the fraction of RV absorbed to be determined and a point-to-point IVIVC to be established. The synthetic membrane, Strat-M™, showed a RV permeation profile similar to that obtained with pig ear skin (R2 = 0.920). Studies with Strat-M™ resulted in a good and linear IVIVC (R2 = 0.991) when compared with other synthetic membranes that showed R2 values less than 0.90. The R2 for pig ear skin was 0.982. Strat-M™ membrane was the only synthetic membrane that adequately simulated skin barrier performance and therefore it can be considered to be a suitable alternative to human or animal skin in evaluating transdermal drug transport, potentially reducing the number of studies requiring human or animal samples. | en |
dc.description.sponsorship | A. Simon thanks CAPES for support to publish this article under Grant No. 3372/13-8. This material is based upon works supported by CAPES (Brasília, Brazil) and the Science 51 Foundation Ireland under Grant No. 12/RC/2275. | en |
dc.format.extent | 234 | en |
dc.format.extent | 241 | en |
dc.relation.ispartofseries | International Journal of Pharmaceutics | en |
dc.relation.ispartofseries | 512 | en |
dc.relation.ispartofseries | 1 | en |
dc.rights | Y | en |
dc.subject | Franz diffusion cell; In vivo-in vitro correlation; Permeation; Point-to-point IVIVC; Rivastigmine; Strat-M™; Synthetic membrane; Transdermal drug delivery system | en |
dc.subject.lcsh | Franz diffusion cell; In vivo-in vitro correlation; Permeation; Point-to-point IVIVC; Rivastigmine; Strat-M™; Synthetic membrane; Transdermal drug delivery system | en |
dc.title | Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/healyam | en |
dc.identifier.rssinternalid | 138198 | en |
dc.identifier.doi | http://dx.doi.org/10.1016/j.ijpharm.2016.08.052 | en |
dc.rights.ecaccessrights | openAccess | |
dc.identifier.rssuri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84983608418&doi=10.1016%2fj.ijpharm.2016.08.052&partnerID=40&md5=543e486009793914342d6d236483b6c4 | en |
dc.identifier.orcid_id | 0000-0001-5093-9786 | en |
dc.contributor.sponsor | Science Foundation Ireland (SFI) | en |
dc.contributor.sponsorGrantNumber | 12/RC/2275 | en |
dc.identifier.uri | http://hdl.handle.net/2262/78790 | |